SOSV

Cradlewise specializes in developing intelligent infant care devices, particularly a smart crib that adapts to a baby's sleep patterns. This innovative crib can detect the early signs of waking and gently bounces the baby back to sleep, mimicking a parent's soothing touch. In addition to its auto-swinging functionality, the device includes integrated contactless monitoring features that track the baby's posture, activity, and breathing rate. By providing real-time insights, Cradlewise enables parents to better care for their children and reduce the risk of sudden infant death syndrome (SIDS). The company aims to enhance the overall well-being of both infants and their caregivers.

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Cradlewise specializes in developing intelligent infant care devices, particularly a smart crib that adapts to a baby's sleep patterns. This innovative crib can detect the early signs of waking and gently bounces the baby back to sleep, mimicking a parent's soothing touch. In addition to its auto-swinging functionality, the device includes integrated contactless monitoring features that track the baby's posture, activity, and breathing rate. By providing real-time insights, Cradlewise enables parents to better care for their children and reduce the risk of sudden infant death syndrome (SIDS). The company aims to enhance the overall well-being of both infants and their caregivers.

Cradlewise specializes in developing intelligent infant care devices, particularly a smart crib that adapts to a baby's sleep patterns. This innovative crib can detect the early signs of waking and gently bounces the baby back to sleep, mimicking a parent's soothing touch. In addition to its auto-swinging functionality, the device includes integrated contactless monitoring features that track the baby's posture, activity, and breathing rate. By providing real-time insights, Cradlewise enables parents to better care for their children and reduce the risk of sudden infant death syndrome (SIDS). The company aims to enhance the overall well-being of both infants and their caregivers.

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Our mission is to translate ground-breaking science into innovative products that empower families to raise lifelong learners. Founded by a Stanford neuroscientist and a father of 2 young boys, our first product is Wunder, which is the first personalized, science-based platform to help new parents lead their little ones learning journey through play, imagination, and collaborative curiosity. The first idea for Oyalabs came about when our founder's first son was born with a congenital medical condition and he was looking for a science-based resource for parents to ensure they are stimulating not just physical but also cognitive development of their child - knowing 0-3 is the most critical period for intervention as 90% of the brain grows then. After positive results from a clinical study, in Summer 2017, we created Wunder to help harness predictive technologies to build tools to nurture not only Lamont’s own sons, as well as something meaningful and impactful for all families. Our technology has been shown to improve a child's language and cognitive outcomes in a research trial and has won the Best of BabyTech Learn & Play award at CES 2018. Based on the data and interactive curriculum in the Wunder app, the platform recommends parents age-appropriate activities, books and toys to teach and motivate parents to provide the most stimulating learning experience for their everyday bonding. Wunder is currently in Beta and parents with children between 0-24 months can apply to get access here: www.hellowunder.com/beta

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Hello, Peanut™ enables parents to easily and gradually introduce small amounts of peanut to their infant, as early as five months of age, over the course of seven days. It is designed to be mixed into first stage foods, and thus can be presented much earlier than other peanut products. After the introductory week, the Hello, Peanut!™ maintenance packets are recommended for infants until they can eat peanut in spread or whole form. Hello, Peanut!™ is geared toward the general infant population. High risk infants (history of eczema and/or existing food allergy) need to be evaluated by their pediatrician or allergist prior to peanut introduction. Hello, Peanut!™ is not designed to treat or cure any form of food allergy.

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Hello, Peanut™ enables parents to easily and gradually introduce small amounts of peanut to their infant, as early as five months of age, over the course of seven days. It is designed to be mixed into first stage foods, and thus can be presented much earlier than other peanut products. After the introductory week, the Hello, Peanut!™ maintenance packets are recommended for infants until they can eat peanut in spread or whole form. Hello, Peanut!™ is geared toward the general infant population. High risk infants (history of eczema and/or existing food allergy) need to be evaluated by their pediatrician or allergist prior to peanut introduction. Hello, Peanut!™ is not designed to treat or cure any form of food allergy.

Our mission is to translate ground-breaking science into innovative products that empower families to raise lifelong learners. Founded by a Stanford neuroscientist and a father of 2 young boys, our first product is Wunder, which is the first personalized, science-based platform to help new parents lead their little ones learning journey through play, imagination, and collaborative curiosity. The first idea for Oyalabs came about when our founder's first son was born with a congenital medical condition and he was looking for a science-based resource for parents to ensure they are stimulating not just physical but also cognitive development of their child - knowing 0-3 is the most critical period for intervention as 90% of the brain grows then. After positive results from a clinical study, in Summer 2017, we created Wunder to help harness predictive technologies to build tools to nurture not only Lamont’s own sons, as well as something meaningful and impactful for all families. Our technology has been shown to improve a child's language and cognitive outcomes in a research trial and has won the Best of BabyTech Learn & Play award at CES 2018. Based on the data and interactive curriculum in the Wunder app, the platform recommends parents age-appropriate activities, books and toys to teach and motivate parents to provide the most stimulating learning experience for their everyday bonding. Wunder is currently in Beta and parents with children between 0-24 months can apply to get access here: www.hellowunder.com/beta

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

BioNascent, Inc. is a San Francisco-based company founded in 2016 that specializes in producing human breast milk formulas for infants. The company aims to provide the safest and most nutritious infant formula without relying on traditional farm animals. Recognizing that babies require human breast milk, BioNascent is focused on developing vegan formula-based products that closely mimic the composition of human milk. These formulas are designed to deliver essential nutrients, including amino acids and carbohydrates, that are critical for infant development. By improving upon existing alternatives that rely on animal milk, BioNascent seeks to enhance infant nutrition options for families, addressing the limitations of traditional dairy and offering a more suitable substitute when breastfeeding is not possible.

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.